Marta Costa

ORCID: 0000-0002-4287-0659
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Synthesis of Organic Compounds
  • Multicomponent Synthesis of Heterocycles
  • Synthesis and biological activity
  • Bioactive Compounds and Antitumor Agents
  • Synthesis and Reactivity of Heterocycles
  • Synthesis and pharmacology of benzodiazepine derivatives
  • Bipolar Disorder and Treatment
  • Synthesis of heterocyclic compounds
  • Synthesis and Biological Evaluation
  • Synthesis and Reactions of Organic Compounds
  • Click Chemistry and Applications
  • Genetics and Neurodevelopmental Disorders
  • Cancer, Hypoxia, and Metabolism
  • Cyclopropane Reaction Mechanisms
  • Nanoplatforms for cancer theranostics
  • Plant biochemistry and biosynthesis
  • Synthesis and Characterization of Heterocyclic Compounds
  • Traditional and Medicinal Uses of Annonaceae
  • Adenosine and Purinergic Signaling
  • Cannabis and Cannabinoid Research
  • Genetic Syndromes and Imprinting
  • Nanoparticle-Based Drug Delivery
  • Essential Oils and Antimicrobial Activity
  • Cancer Mechanisms and Therapy
  • Chemical Synthesis and Reactions

University of Minho
2013-2024

Administração Regional de Saúde de Lisboa e Vale do Tejo
2024

Oxford Health NHS Foundation Trust
2024

University of Lisbon
2023

The Francis Crick Institute
2018

University College London
2017

CRUK Lung Cancer Centre of Excellence
2017

London Cancer
2017

University of Cagliari
2011-2015

Universidade Federal do Rio Grande do Norte
2006-2011

Nicholas McGranahan Rachel Rosenthal Crispin T. Hiley Andrew J. Rowan Thomas B.K. Watkins and 95 more Gareth A. Wilson Nicolai J. Birkbak Selvaraju Veeriah Peter Van Loo Javier Herrero Charles Swanton Charles Swanton Mariam Jamal‐Hanjani Selvaraju Veeriah Seema Shafi Justyna Czyzewska-Khan Diana Johnson Joanne Laycock Leticia Bosshard‐Carter Rachel Rosenthal Pat Gorman Robert E. Hynds Gareth A. Wilson Nicolai J. Birkbak Thomas B.K. Watkins Nicholas McGranahan Stuart Horswell Richard Mitter Mickael Escudero Aengus Stewart Peter Van Loo Andrew Rowan Hang Xu Samra Turajlic Crispin T. Hiley Christopher Abbosh Jacki Goldman Richard Stone Tamara Denner Nik Matthews Greg Elgar Sophia Ward Marta Costa Sharmin Begum Ben Phillimore Tim Chambers Emma Nye Sofia Graca Maise Al Bakir Kroopa Joshi Andrew J.S. Furness Assma Ben Aïssa Yien Ning Sophia Wong Andy Georgiou Sergio A. Quezada John A. Hartley Helen L. Lowe Javier Herrero David Lawrence Sophia Ward Nikolaos Panagiotopoulos Shyam Kolvekar Mary Falzon Elaine Borg Teresa Marafioti Celia Simeon Gemma Hector Amy Smith Marie Aranda Marco Novelli Dahmane Oukrif Sam M. Janes Ricky M. Thakrar Martin Förster Tanya Ahmad SM Lee Dionysis Papadatos-Pastos Dawn Carnell R. Mendes Jeremy George Neal Navani Asia Ahmed Magali N. Taylor Junaid Choudhary Yvonne Summers Raffaele Califano P. W. J. Taylor Rajesh Shah Piotr Krysiak Kendadai Rammohan Eustace Fontaine Richard Booton Matthew Evison Philip Crosbie Stuart Moss Faiza Idries Leena Dennis Joseph Paul N. Bishop Anshuman Chaturved Anne Marie Quinn

Immune evasion is a hallmark of cancer. Losing the ability to present neoantigens through human leukocyte antigen (HLA) loss may facilitate immune evasion. However, polymorphic nature locus has precluded accurate HLA copy-number analysis. Here, we heterozygosity in (LOHHLA), computational tool determine allele-specific copy number from sequencing data. Using LOHHLA, find that LOH occurs 40% non-small-cell lung cancers (NSCLCs) and associated with high subclonal neoantigen burden,...

10.1016/j.cell.2017.10.001 article EN cc-by Cell 2017-10-26

The evolutionary features of clear-cell renal cell carcinoma (ccRCC) have not been systematically studied to date. We analyzed 1,206 primary tumor regions from 101 patients recruited into the multi-center prospective study, TRACERx Renal. observe up 30 driver events per and show that subclonal diversification is associated with known prognostic parameters. By resolving patterns event ordering, co-occurrence, mutual exclusivity at clone level, we deterministic nature clonal evolution. ccRCC...

10.1016/j.cell.2018.03.043 article EN cc-by Cell 2018-04-01
Frederick Arce Vargas Andrew J.S. Furness Isabelle Solomon Kroopa Joshi Leila Mekkaoui and 95 more Marta H. Lesko Enrique Miranda Rony Dahan Andrew Georgiou Anna Śledzińska Assma Ben Aïssa Dafne Franz Mariana Werner Sunderland Yien Ning Sophia Wong Jake Y. Henry Tim O’Brien David Nicol Ben Challacombe Stephen A. Beers Samra Turajlic Martin Gore James Larkin Charles Swanton Kerry Chester Martin Pulé Jeffrey V. Ravetch Teresa Marafioti Karl S. Peggs Sergio A. Quezada Lavinia Spain Andrew Wotherspoon Nick Francis Myles Smith D. Strauß Andrew J. Hayes Aspasia Soultati Mark Stares Lavinia Spain Joanna Lynch Nicos Fotiadis Archana Fernando Steve Hazell Ashish Chandra Lisa Pickering Sarah Rudman Simon Chowdhury Charles Swanton Mariam Jamal‐Hanjani Selvaraju Veeriah Seema Shafi Justyna Czyzewska-Khan Diana Johnson Joanne Laycock Leticia Bosshard‐Carter Gerald Goh Rachel Rosenthal Pat Gorman Nirupa Murugaesu Robert E. Hynds Gareth A. Wilson Nicolai J. Birkbak Thomas B.K. Watkins Nicholas McGranahan Stuart Horswell Richard Mitter Mickael Escudero Aengus Stewart Peter Van Loo Andrew Rowan Hang Xu Samra Turajlic Crispin T. Hiley Christopher Abbosh Jacki Goldman Richard Stone Tamara Denner Nik Matthews Greg Elgar Sophia Ward Jennifer Biggs Marta Costa Sharmin Begum Ben Phillimore Tim Chambers Emma Nye Sofia Graca Maise Al Bakir John A. Hartley Helen L. Lowe Javier Herrero David Lawrence Sophia Ward Nikolaos Panagiotopoulos Shyam Kolvekar Mary Falzon Elaine Borg Celia Simeon Gemma Hector Amy Smith Marie Aranda

CD25 is expressed at high levels on regulatory T (Treg) cells and was initially proposed as a target for cancer immunotherapy. However, anti-CD25 antibodies have displayed limited activity against established tumors. We demonstrated that expression largely restricted to tumor-infiltrating Treg in mice humans. While existing were observed deplete the periphery, upregulation of inhibitory Fc gamma receptor (FcγR) IIb tumor site prevented intra-tumoral cell depletion, which may underlie lack...

10.1016/j.immuni.2017.03.013 article EN cc-by Immunity 2017-04-01

Proliferating cancer cells are able to reprogram their energy metabolism, favouring glycolysis even in the presence of oxygen and fully functioning mitochondria. Research is needed validate glycolysis-related proteins as prognostic/predictive biomarkers urothelial bladder carcinoma (UBC), a malignancy tagged by high recurrence rates poor response chemotherapy. Here, we assessed GLUT1, HK2, PFKL, PKM2, phospho-PDH, LDHA immunoexpression 76 UBC samples, differentiating among urothelial,...

10.3390/cancers15030982 article EN Cancers 2023-02-03

Bipolar disorder (BD) is a lifelong psychiatric illness characterized by manic and depressive episodes affecting 1-5% of the general population. Among mood-stabilizing treatments, lithium represents mainstay in therapeutic management BD. However, besides relatively high rate excellent responders, significant fraction patients present patterns partial or nonresponse to lithium. This variability might be influenced genetic factors, even though findings have so far been inconclusive. Here, we...

10.2217/pgs.11.102 article EN Pharmacogenomics 2011-10-03

Bipolar disorder (BD) is a debilitating psychiatric disease characterized by alternating episodes of mania and depression. Among mood stabilizers, lithium the mainstay for treatment BD, with approximately one-third patients showing remission from episode recurrence. While there evidence suggesting genetic load response in its molecular underpinnings are still not completely understood. To identify genes potentially involved (or correlated with) response, we carried out genome-wide expression...

10.1016/j.phrs.2013.04.004 article EN cc-by-nc-nd Pharmacological Research 2013-04-22

The reaction of salicylic aldehydes with malononitrile was reinvestigated, and the pathway followed by 1H NMR spectroscopy. A delicate control experimental conditions allowed synthesis 2-imino-2H-chromene-3-carbonitriles 1, (2-amino-3-cyano-4H-chromen-4-yl)malononitriles 2, 4-amino-5-imino-2,7-dimethoxy-5H-chromeno[3,4-c]pyridine-1-carbonitrile 12, (4,5-diamino-1-cyano-1,10b-dihydro-2H-chromeno[3,4-c]pyridin-2-ylidene)malononitrile 13. Two novel 2-iminochromene dimers, structures 8 9, were...

10.1021/jo702552f article EN The Journal of Organic Chemistry 2008-02-14

Triple-negative breast cancer (TNBC) represents 15-25 % of the new cases diagnosed worldwide every year. TNBC is among most aggressive and worst prognosis cancer, mainly because targeted therapies are not available. Herein, we developed a magnetic theranostic hybrid nanovehicle for treatment through pH-triggered tumour associated macrophages (TAMs) targeting. The lipid core was composed Carnaúba wax matrix that simultaneously incorporated iron oxide nanoparticles doxorubicin (DOX) -...

10.1016/j.ijpharm.2022.122575 article EN cc-by-nc-nd International Journal of Pharmaceutics 2023-01-02

"O Vírus da Leucemia Felina é um vírus disseminado mundialmente, onde se trata de Retrovírus. A FeLV pode evoluir para quatro tipos infecções, sendo elas a infecção progressiva, regressiva, abortiva e atípica ou focal, sua evolução vai depender do sistema imunológico felino subgrupo que esteja acometendo esse paciente. Seus sinais clínicos são inespecíficos o diagnóstico ser feito através ELISA, Imunocromatofragia, Imunofluorescência Indireta PCR, juntamente hemograma completo associado ao...

10.29327/1505793.33-3 article PT 2025-01-01

A series of new 2-imino-2H-chromene-3-carboxamides 5 were synthesized in excellent yield and high atom economy by the Knoevenagel condensation salicylaldehyde derivatives 4 N-substituted cyanoacetamides 3 using aqueous sodium carbonate or hydrogen solution, at room temperature. Treatment compounds with HCl led to formation corresponding 2-oxochromenes 6.

10.1039/b807892k article EN Green Chemistry 2008-01-01

Triple negative breast cancer (TNBC) is a highly heterogenous disease not sensitive to endocrine or HER2 therapy and standardized treatment regimens are still missing. Therefore, development of novel TNBC approaches utmost relevance. Herein, the potential MAPK/ERK downregulation by RNAi-based therapeutics in panel mesenchymal stem-like cell lines was uncovered. Our data revealed that suppression one central nodes this signaling pathway, MEK1, affects proliferation, migration, invasion cells,...

10.1016/j.bioadv.2023.213643 article EN cc-by-nc Biomaterials Advances 2023-09-28
Coming Soon ...